Search

everythinglearnresearchcommunity

for

Search:↓

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

c-Kit is important for heart regeneration and cancer development.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

Computational methods help design drugs targeting prostate cancer proteins.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

CDP is crucial for lung and hair follicle cell development.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Blocking LFA-1 prevents hair loss in mice.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

CD34 marks potential stem cells in dog hair follicles.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Inhibiting ODC can prevent UV-induced skin cancer.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

CD90 is abundantly present on stem-like cells in dog hair follicles.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

cDermo-1 causes dense skin, feathers, and scales in chickens.

CXCR2 in skin cells promotes tumor growth.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

pCLCA2 protein may help maintain skin structure and function.

Basal cell carcinomas may use IDO to protect themselves from the immune system.